Letermovir: Difference between revisions
From IDWiki
(Created page with "* Antiviral * Oral and intravenous * Increases bioavailability of cyclosporine * No renal adjustment needed * Indications: {{#ask: Is treated by::letermovir | default=...") |
No edit summary |
||
Line 1: | Line 1: | ||
+ | * Antiviral that targets subunit 2 of the viral terminase complex (UL56) in [[cytomegalovirus]] |
||
− | * Antiviral |
||
* Oral and intravenous |
* Oral and intravenous |
||
* Increases bioavailability of [[cyclosporine]] |
* Increases bioavailability of [[cyclosporine]] |
||
* No renal adjustment needed |
* No renal adjustment needed |
||
* Indications: {{#ask: [[Is treated by::letermovir]] | default=none}} |
* Indications: {{#ask: [[Is treated by::letermovir]] | default=none}} |
||
+ | ** No activity against [[HSV]] or [[VZV]] |
||
[[Category:Antivirals]] |
[[Category:Antivirals]] |
Revision as of 10:22, 24 October 2019
- Antiviral that targets subunit 2 of the viral terminase complex (UL56) in cytomegalovirus
- Oral and intravenous
- Increases bioavailability of cyclosporine
- No renal adjustment needed
- Indications: Cytomegalovirus